What Lucideon does

Lucideon is a UK-headquartered development and commercialization organization (DCO) specializing in materials science and technology services, operating from Staffordshire with a newer US facility in Greenville, South Carolina. The company is organized around two principal service lines: (1) medical device biocompatibility and biological testing — including cytotoxicity, extractables and leachables, toxicological risk assessment, and implant performance testing — delivered through its Greenville lab and an in vitro cell biology laboratory in Staffordshire developed with Queen Mary University of London; and (2) advanced ceramics development and characterization, covering ceramic additive manufacturing (in partnership with Hydra Manufacturing), nuclear waste container integrity testing, proprietary ceramic ink formulations, SNBSC and silicon carbide processing R&D, and fusion-energy-grade ceramics under UKAEA contracts. Technical differentiation rests on proprietary processing IP (e.g., viscous plastic processing of SiC achieving 86% theoretical density below 2000°C, SNBSC robocasting at 99.7% nitriding) and embedded positions within UK research infrastructure such as the £18.27m Midlands Industrial Ceramics Group and AMRICC Centre.

Lucideon monetizes primarily through professional services: testing fees for medical device regulatory compliance, government and institutional research contracts (UKAEA, UKNNL, ESA consortium), and collaborative materials development engagements with industrial clients in medical devices, aerospace, and nuclear sectors. The company has no publicly disclosed pricing; engagements are scoped and contracted per project. It sells through direct enterprise engagement with engineering and procurement teams, supplemented by technical presence at industry events such as Ceramics Expo USA and the Next Generation Industry Conference. Its customer base spans medical device manufacturers (primary segment), nuclear operators and government bodies, fusion energy research organizations, and aerospace/advanced manufacturers, with notable named engagements including Sellafield Ltd (via UKNNL), UKAEA, and an ESA-funded Metalysis-led titanium consortium. The company is privately held as Lucideon Ltd, with no parent company or institutional investor identified in the available data.

Name

Lucideon

Legal name

Lucideon Ltd

Website

https://lucideon.com

Company type

Private

Founded year

1948

Operating status

Operating

Headcount range

101–250 employees

Short description

Lucideon is a UK-based development and commercialization organization providing materials science services — including medical device biocompatibility testing and advanced ceramics development for nuclear, fusion, and aerospace clients — across facilities in Staffordshire and Greenville, South Carolina.

Ownership category

akta.pro rank

Headquarters

HQ city

Stafford

HQ country

United Kingdom

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales

Revenue model

1. Biocompatibility Testing Services: Comprehensive testing services for medical devices including cytotoxicity, extractables and leachables testing, toxicological risk assessment, and advanced implant performance assessments. Revenue generated through testing fees for regulatory compliance.
2. Research Contracts: Government and institutional research contracts including work for UK Atomic Energy Authority under Fusion Futures Industry Capability Programme and UK National Nuclear Laboratory for nuclear industry testing.
3. Materials Development and Consulting: Collaborative materials development including ceramic additive manufacturing solutions and advanced ceramics development for specialized applications in aerospace and industrial manufacturing.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Core offering

Lucideon is a development and commercialization organization that provides advanced materials testing, characterization, and development services. Its core offerings include medical device biocompatibility testing (cytotoxicity, extractables and leachables, toxicological risk assessment, implant performance) through laboratories in Greenville, SC and Staffordshire, UK, and advanced ceramics research covering ceramic additive manufacturing, nuclear waste container integrity testing, and fusion-energy ceramics for UKAEA. Revenue is generated primarily through project-based testing fees and collaborative materials development contracts with enterprise and government clients.

Product overview

Lucideon is an international technology company offering a portfolio of advanced materials testing and development services. The company operates two complementary core offerings: (1) medical device biocompatibility testing through its laboratories in Greenville, South Carolina and Staffordshire, UK, providing cytotoxicity, extractables and leachables testing, toxicological risk assessment, and implant performance assessments; and (2) advanced ceramics development including ceramic additive manufacturing solutions (via Hydra collaboration), nuclear waste container integrity testing, SNBSC kiln furniture materials, viscous plastic processing of silicon carbide, and fusion energy ceramics research for UKAEA. Additionally, Lucideon participates in the Metalysis ESA consortium for sustainable titanium production and supports the AMRICC Academy for ceramics sector training.

Differentiator

Problem solved

Functional benefit

Products and services

• Biocompatibility Testing Laboratory - Greenville State-of-the-art facility in Greenville, South Carolina providing comprehensive medical device biocompatibility testing — including cytotoxicity, extractables and leachables testing, toxicological risk assessment, and advanced implant performance assessments — for medical device manufacturers needing to verify biological safety and meet FDA and international regulatory requirements.
• In Vitro Cell Biology Laboratory Complementary in vitro cell biology laboratory in Staffordshire, UK, developed in partnership with Queen Mary University of London's School of Engineering and Materials Science, supporting advanced biological testing for medical device manufacturers.
• Ceramic Additive Manufacturing Solutions Ceramic additive manufacturing offering combining proprietary ceramic ink formulation with materials testing expertise, delivered in collaboration with Hydra Manufacturing (CHAMP printer), enabling complex, high-tolerance ceramic components for aerospace and advanced manufacturing customers.
• Nuclear Waste Container Integrity Testing Integrity testing service for nuclear waste storage containers, including drop tests from up to 13 meters, 3D laser surface scanning, and underwater immersion with residual gas collection, contracted by UK National Nuclear Laboratory on behalf of Sellafield Ltd.
• Silicon Nitride-Bonded Silicon Carbide (SNBSC) Materials Low-shrinkage advanced ceramic material developed for kiln furniture in aerospace and advanced ceramics manufacturing, produced via robocasting additive manufacturing with near-complete nitriding (99.7%) and minimal dimensional change.
• Viscous Plastic Processing of Silicon Carbide Research formulation of silicon carbide paste using viscous plastic processing with sintering aids, achieving pressureless sintering below 2000°C with 86% theoretical density for advanced ceramics.
• Fusion Energy Ceramics Research Research contracts with UK Atomic Energy Authority (UKAEA) under the Fusion Futures Industry Capability Programme, focusing on creating advanced ceramics capable of withstanding extreme temperatures and neutron damage inside fusion machines.
• Sustainable Titanium Production (Metalysis Consortium) Consortium participation in ESA-funded 24-month programme led by Metalysis to develop continuous sustainable titanium production using the FFC electrochemical process, with Lucideon contributing materials testing and characterization expertise for space and aerospace supply chain applications.
• AMRICC Academy Training Programmes Educational and training programmes for scientists and engineers in traditional and advanced ceramics, addressing the long-standing skills gap in the ceramics sector, delivered through the AMRICC Centre in Staffordshire, UK.

Quantifiable outcome

• Near-complete nitriding (99.7%) achieved for SNBSC ceramic materials via additive manufacturing
• +1 more outcomes

Named customers2 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Ten partnerships are on record, tiered core and minor.

• Queen Mary University of London (School of Engineering and Materials Science)coreStrategic or Co-development Partner · 1 May 2026Partnership to develop and operate an in vitro cell biology laboratory in Staffordshire, UK. This collaboration creates academic rigor and research capabilities in biological testing, complementing Lucideon's commercial testing services and supporting advanced medical device testing methodologies.
• Hydra ManufacturingcoreStrategic or Co-development Partner · 1 April 2026Collaboration to advance ceramic additive manufacturing solutions, combining Hydra's CHAMP printer technology with Lucideon's ceramic ink formulation and materials testing expertise. The partnership leverages Hydra's in-situ green machining capability and Lucideon's access to the AMRICC Centre's processing facilities for scale-up and commercialization of complex ceramic geometries.
• MetalysisminorStrategic or Co-development Partner · 1 March 2026Consortium partner in ESA-funded 24-month programme to develop continuous sustainable titanium production using Metalysis' patented FFC Process. Lucideon contributes materials testing and characterization expertise to support scale-up of titanium production technology for space and aerospace applications.
• TTP PlcminorStrategic or Co-development Partner · 1 March 2026Consortium partner in ESA titanium production project focused on developing continuous sustainable titanium production methods for Western supply chain security.
• NCHG LtdminorStrategic or Co-development Partner · 1 March 2026Consortium partner in ESA titanium production project contributing to development of sustainable titanium supply chain for aerospace and defense applications.
• UK Atomic Energy Authority (UKAEA)coreStrategic or Co-development Partner · 1 December 2025Awarded three research contracts by UKAEA under the Fusion Futures Industry Capability Programme. Lucideon will focus on creating advanced ceramics capable of withstanding extreme temperatures and neutron damage inside fusion machines, drawing on expertise and facilities at its Staffordshire headquarters and The AMRICC Centre.
• Science and Technology Facilities CouncilcoreStrategic or Co-development Partner · 1 May 2025Key partner in AMRICC Centre, a £10m educational and research facility within the Midlands Industrial Ceramics Group's £18.27m research programme. Contributes to training programmes for scientists and engineers in the ceramics sector.
• Hartree CentrecoreStrategic or Co-development Partner · 1 May 2025Key partner in AMRICC Centre contributing computational and data science capabilities to advanced ceramics research and development programmes.
• Ceramic Technology AcademycoreStrategic or Co-development Partner · 1 May 2025Partner in AMRICC Academy providing specialized training programmes for scientists and engineers in both traditional and advanced ceramics, addressing long-standing skills gap in the sector.
• Axia Value SolutionsminorStrategic or Co-development Partner · 1 May 2025Partner in AMRICC Centre contributing to the educational hub for ceramics sector training and skills development in Staffordshire, UK.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Exponent: Engineering and scientific consulting firm combining laboratory testing, failure analysis, and expert testimony. Comparable in multidisciplinary materials failure analysis and expert-driven services.
• NAMSA: Medical device-focused testing and consulting organization offering biocompatibility, sterilization, and regulatory services. Directly overlaps with Lucideon's Greenville and Staffordshire medical device testing offerings.
• Mersen: French advanced materials company with strong portfolio in technical ceramics, graphite, and electrical applications. Comparable in advanced ceramics development and qualification for extreme environments.
• Element Materials Technology: Global materials testing and product qualification services provider with similar breadth across aerospace, medical, and industrial sectors. Closest direct comparable in materials characterization and failure analysis services.
• Smithers Group: Independent testing, consulting, and contract research firm with strong materials, medical device, and polymer testing capabilities. Directly comparable in scope and client mix to Lucideon's testing business.
• Morgan Advanced Materials: UK-based manufacturer of advanced ceramics and carbon-based materials for aerospace, medical, and industrial applications. Comparable in advanced ceramics IP and sector overlap.

Broad incumbents

• Saint-Gobain: Major industrial group with significant advanced ceramics and high-performance materials operations. Comparable in ceramics and materials science but operates across an enormous portfolio of construction and industrial businesses.
• Eurofins Scientific: Global testing services conglomerate with growing medical device and materials characterization capabilities. Comparable services but at vastly larger scale and broader portfolio.
• CoorsTek: Largest privately held technical ceramics manufacturer globally, serving semiconductor, medical, aerospace, and industrial customers. Comparable end-markets but at vastly larger manufacturing scale.
• Intertek Group: Global TIC giant with broad materials, product, and certification services across all sectors Lucideon targets. Comparable services but at vastly larger scale and broader portfolio.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/_Lucideon

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Lucideon